Best Practices for Documenting Amendment Rollout
Protocol amendments are inevitable in clinical trials. Whether minor administrative edits or major safety-impacting revisions, these changes require effective communication and documentation across all participating sites. Regulatory authorities like the USFDA and EMA expect sponsors and CROs to maintain a clear, auditable trail of amendment rollout activities.
Click to read the full article.